Your browser doesn't support javascript.
loading
Sustained Benefits from Ranibizumab for Central Retinal Vein Occlusion with Macular Edema: 24-Month Results of the CRYSTAL Study.
Larsen, Michael; Waldstein, Sebastian M; Priglinger, Siegfried; Hykin, Philip; Barnes, Elizabeth; Gekkieva, Margarita; Das Gupta, Ayan; Wenzel, Andreas; Monés, Jordi.
Afiliação
  • Larsen M; Department of Ophthalmology, Rigshospitalet and Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark. Electronic address: miclar01@regionh.dk.
  • Waldstein SM; Department of Ophthalmology, Vienna Reading Center, Medical University of Vienna, Vienna, Austria.
  • Priglinger S; Department of Ophthalmology, Ludwig-Maximilians-University, Munich, Germany.
  • Hykin P; Moorfields Eye Hospital, London, United Kingdom.
  • Barnes E; Novartis Pharma AG, Basel, Switzerland.
  • Gekkieva M; Novartis Pharma AG, Basel, Switzerland.
  • Das Gupta A; Novartis Healthcare Pvt Ltd, Hyderabad, India.
  • Wenzel A; Novartis Pharma AG, Basel, Switzerland.
  • Monés J; Institut de la Màcula, Centro Médico Teknon, and Barcelona Macula Foundation, Barcelona, Spain.
Ophthalmol Retina ; 2(2): 134-142, 2018 02.
Article em En | MEDLINE | ID: mdl-31047340

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Oclusão da Veia Retiniana / Acuidade Visual / Edema Macular / Ranibizumab Tipo de estudo: Clinical_trials / Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Oclusão da Veia Retiniana / Acuidade Visual / Edema Macular / Ranibizumab Tipo de estudo: Clinical_trials / Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male Idioma: En Ano de publicação: 2018 Tipo de documento: Article